Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents

por Zapata-Sudo, Gisele, da Costa Nunes, Isabelle Karine, Araujo, Josenildo Segundo Chaves, da Silva, Jaqueline Soares, Trachez, Margarete Manhães, da Silva, Tiago Fernandes, da Costa, Filipe P, Sudo, Roberto Takashi, Barreiro, Eliezer J, Lima, Lídia Moreira
Publicado en Drug Des Devel Ther (2016)

Effects of the FGF receptor‐1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension

por Felix, Nathane Santanna, de Mendonça, Lucas, Braga, Cassia Lisboa, da Silva, Jaqueline Soares, Samary, Cynthia dos Santos, Vieira, Juliana Borges, Cruz, Fernanda, Rocha, Nazareth de Novaes, Zapata‐Sudo, Gisele, Rocco, Patricia Rieken Macedo, Silva, Pedro Leme
Publicado en Br J Pharmacol (2019)

New Benzofuran N-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis

por Costa, Gizele Cabral, Montagnoli, Tadeu Lima, Da Silva, Jaqueline Soares, de Alencar, Allan Kardec Nogueira, Reina Gamba, Luis Eduardo, Alves, Bryelle Eccard Oliveira, da Silva, Marina Moraes Carvalho, Trachez, Margarete Manhães, do Nascimento, José Hamilton M, Pimentel-Coelho, Pedro Moreno, Mendez-Otero, Rosália, Lima, Lidia Moreira, Barreiro, Eliezer J, Sudo, Roberto Takashi, Zapata-Sudo, Gisele
Publicado en Drug Des Devel Ther (2020)